On Friday, Novadaq Technologies Inc. (NASDAQ:NVDQ)’s shares declined -15.12% to $13.75.
Novadaq Technologies Inc. (NVDQ) will declare financial results for the first quarter of 2015 after market close on Tuesday, April 28, 2015.
NOVADAQ President and CEO, Arun Menawat and CFO, Roger Deck, will host a conference call at 4:30 p.m. ET to review the financial results and talk about business developments in the period.
Novadaq Technologies Inc. develops, manufactures, and markets fluorescence imaging products and therapeutic devices for use by surgeons in the operating room and other clinical settings in the United States and internationally.
PROS Holdings, Inc. (NYSE:PRO)’s shares dropped -14.92% to $23.10.
PROS Holdings, Inc. (PRO) declared preliminary financial results for the first quarter ended March 31, 2015.
Based on preliminary financial information, PROS presently anticipates to report total non-GAAP revenue for the first quarter of 2015 in the range of $44.3 million to $44.8 million, below the Company’s guidance of $47.0 million to $49.0 million.
Moreover, PROS Holdings, Inc. will host a conference call on Thursday, May 7, 2015, at 4:30 p.m. ET to talk about the Company’s financial results and business outlook.
PROS Holdings, Inc. provides big data software applications worldwide. It offers pricing and sales effectiveness software solutions that enable companies in the manufacturing, distribution, and services industries to analyze, optimize, and execute sales, pricing, quoting, and rebate strategies, such as Scientific Analytics, Price Optimizer, Deal Optimizer, Sales Optimizer, and Cameleon configure-price-quote.
At the end of Friday’s trade, ServiceNow Inc (NYSE:NOW)‘s shares dipped -11.53% to $73.29.
ServiceNow Inc (NOW) unveiled the financial results for its first quarter 2015.
First Quarter 2015 Results:
- Revenues of $212 million, a raise of 52% year-over-year and 62% in constant currency.
- GAAP net loss of $58 million, or a loss of $0.38 per basic and diluted share, contrast to a GAAP net loss of $43 million, or a loss of $0.30 per basic and diluted share, in the first quarter of 2014.
- Non-GAAP net income of $2 million, or income of $0.02 per basic share and $0.01 per diluted share, contrast to a non-GAAP net loss of $11 million, or a loss of $0.08 per basic and diluted share, in the first quarter of 2014.
- Billings were $268 million, increasing 48% year-over-year and 59% in constant currency.
- Added 23 net new Global 2000 customers, bringing the total to 545.
ServiceNow, Inc. provides cloud-based solutions that define structure, manage, and automate services to enterprise operations in North America, Europe, the Middle East, Africa, the Asia Pacific, and other countries.
Solazyme Inc (NASDAQ:SZYM), ended its Friday’s trading session with -11.31% loss, and closed at $3.92.
Solazyme Inc (SZYM) and Flotek Industries, declared the companies and certain auxiliaries have reached contracts to globally commercialize Flocapso™, an innovative, advanced drilling fluid additive. In addition, Flotek will market Solazyme’s Encapso™ lubricant - the first commercially accessible, biodegradable encapsulated lubricant for drilling fluids – in certain Middle Eastern markets.
Under the Joint Product Development and Marketing Contract (the “Joint Contract”), Flotek and Solazyme will commercialize and market Flocapso, a proprietary formulation combining Flotek’s patented Complex nano-Fluid® chemistries with Solazyme’s proprietary Encapso technology to create an environmentally-conscious, highly effective drilling fluid additive focused on better lubricity and greater stabilization for drilling programs worldwide. Laboratory and commercial testing indicate that the Flocapso additive will allow the use of water-based fluids in wells that formerly required more expensive and invasive oil-based products, providing an environmentally superior, more efficient solution to drilling challenges around the globe.
Solazyme, Inc. manufactures and sells renewable oils and other bioproducts. Its proprietary technology transforms a range of plant-based sugars into triglyceride oils and other bioproducts.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
